Acute Hyperglycemia-Induced Inflammation in MIO-M1 Cells: The Role of Aldose Reductase
International Journal of Molecular Sciences · 14.07.2025 · 26 (14) · 6741
DOI: 10.3390/ijms26146741 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2025. Verfasst von Francesca Felice und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Unit, Department of Biology, University of Pisa, 56123 Pisa, Italy. Hauptthemen laut MEDLINE: Hyperglycemia, Aldehyde Reductase, Inflammation, Ependymoglial Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institution, University of Pisa, Pisa University.
Abstract (Originalsprache)
Diabetic retinopathy (DR), traditionally considered a microvascular complication, is now recognized as a neuroinflammatory disorder involving retinal glial cells. Aldose reductase (AKR1B1), a key enzyme in the polyol pathway, has been implicated in the hyperglycemia-induced inflammatory response in various cell types, although its role in retinal Müller glial cells under acute glucose stress remains unclear. This study investigates AKR1B1 activity and its contribution to inflammatory signaling in MIO-M1 human Müller cells exposed to acute hyperglycemia. AKR1B1 expression and activity, as well as NF-κB activation and COX-2 expression, were evaluated. Sorbinil, a specific AKR1B1 inhibitor, was used to determine the enzyme’s contribution to acute hyperglycemia-induced inflammation. Acute high-glucose treatment significantly increased AKR1B1 activity and sorbitol accumulation without affecting cell viability. In addition, activation of NF-κB and increased expression of cyclooxygenase-2 (COX-2) were observed, both of which were significantly reduced by Sorbinil. Our findings highlight the role of macroglia as active contributors to early inflammatory events in DR and suggest that transient hyperglycemic spikes are sufficient to trigger AKR1B1-dependent glial activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Unit, Department of Biology, University of Pisa, 56123 Pisa, Italy.
- Interdepartmental Research Center Nutrafood "Nutraceuticals and Food for Health", University of Pisa, 56124 Pisa, Italy.
- Center for Instrument Sharing University of Pisa (CISUP), Lungarno Pacinotti, 43/44, 56126 Pisa, Italy.
- National Research Council-CNR, Institute on Clinical Physiology, via Moruzzi 1, 56124 Pisa, Italy.
ORCID-Profile: Francesca Felice, Gemma Sardelli, Mario Cappiello, Antonella Del Corso, Martina Avanatti, Simone Allegrini, Roberta Moschini
Förderung
- Institution, University of Pisa
- Pisa University
Zitieren
APA
Felice, F., Sardelli, G., Balestri, F., Piazza, L., Cappiello, M., Mosca, R., Del Corso, A., Avanatti, M., Allegrini, S., & Moschini, R. (2025). Acute Hyperglycemia-Induced Inflammation in MIO-M1 Cells: The Role of Aldose Reductase. International Journal of Molecular Sciences, 26(14), 6741. https://doi.org/10.3390/ijms26146741
Vancouver
Felice F, Sardelli G, Balestri F, Piazza L, Cappiello M, Mosca R, et al. Acute Hyperglycemia-Induced Inflammation in MIO-M1 Cells: The Role of Aldose Reductase. International Journal of Molecular Sciences. 2025;26(14):6741. doi:10.3390/ijms26146741
BibTeX
@article{Felice2025,
author = {Felice, Francesca and Sardelli, Gemma and Balestri, Francesco and Piazza, Lucia and Cappiello, Mario and Mosca, Rossella and Del Corso, Antonella and Avanatti, Martina and Allegrini, Simone and Moschini, Roberta},
title = {Acute Hyperglycemia-Induced Inflammation in MIO-M1 Cells: The Role of Aldose Reductase},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {14},
pages = {6741},
doi = {10.3390/ijms26146741}
}
EUVIMED